NASDAQ:EXPO - Exponent Stock Price, News, & Analysis

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Exponent declared a quarterly dividend on Friday, October 19th. Stockholders of record on Friday, December 7th will be paid a dividend of $0.13 per share on Friday, December 21st. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date of this dividend is Thursday, December 6th. View Exponent's Dividend History.

Exponent's stock split on the morning of Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly minted shares were payable to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

Exponent, Inc. (NASDAQ:EXPO) posted its quarterly earnings data on Thursday, October, 18th. The business services provider reported $0.32 EPS for the quarter, topping the consensus estimate of $0.29 by $0.03. The business services provider earned $88.71 million during the quarter, compared to the consensus estimate of $88.52 million. Exponent had a net margin of 13.98% and a return on equity of 20.92%. The firm's quarterly revenue was up 7.7% compared to the same quarter last year. During the same period last year, the business earned $0.27 earnings per share. View Exponent's Earnings History.

Exponent is scheduled to release their next quarterly earnings announcement on Thursday, February 7th 2019. View Earnings Estimates for Exponent.

3 brokers have issued 12 month price objectives for Exponent's shares. Their forecasts range from $24.00 to $56.00. On average, they expect Exponent's stock price to reach $40.00 in the next year. This suggests that the stock has a possible downside of 19.7%. View Analyst Price Targets for Exponent.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Exponent.

Media stories about EXPO stock have been trending very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Exponent earned a daily sentiment score of -3.8 on InfoTrie's scale. They also assigned news articles about the business services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near term.

Exponent saw a increase in short interest in November. As of November 15th, there was short interest totalling 934,618 shares, an increase of 32.5% from the October 31st total of 705,153 shares. Based on an average daily volume of 256,745 shares, the days-to-cover ratio is presently 3.6 days. Approximately 1.8% of the shares of the company are short sold. View Exponent's Current Options Chain.

Some companies that are related to Exponent include Booz Allen Hamilton (BAH), Genpact (G), FTI Consulting (FCN), RMR Group (RMR), ICF International (ICFI), Huron Consulting Group (HURN), Navigant Consulting (NCI), NIC (EGOV), The Hackett Group (HCKT), Blackrock Capital Investment (BKCC), Avalon Globocare (AVCO), Information Services Group (III), Gopher Protocol (GOPH), Wilhelmina International (WHLM) and China Internet Nationwide Fncl Srvcs (CIFS).

Exponent's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.39%), Vanguard Group Inc. (9.90%), Vanguard Group Inc (9.90%), Neuberger Berman Group LLC (7.40%), Conestoga Capital Advisors LLC (4.33%) and Dimensional Fund Advisors LP (3.31%). Company insiders that own Exponent stock include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss and Sally Shepard. View Institutional Ownership Trends for Exponent.

EXPO stock was sold by a variety of institutional investors in the last quarter, including DF Dent & Co. Inc., Atlanta Capital Management Co. L L C, Renaissance Technologies LLC, Neuberger Berman Group LLC, Panagora Asset Management Inc., Copeland Capital Management LLC, JPMorgan Chase & Co. and PNC Financial Services Group Inc.. Company insiders that have sold Exponent company stock in the last year include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Richard L Schlenker Jr and Richard Reiss. View Insider Buying and Selling for Exponent.

EXPO stock was bought by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, WINTON GROUP Ltd, BlackRock Inc., Sandler Capital Management, Vanguard Group Inc, Vanguard Group Inc., Morgan Stanley and Marshall Wace LLP. View Insider Buying and Selling for Exponent.

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of EXPO stock can currently be purchased for approximately $49.81.

Exponent has a market capitalization of $2.63 billion and generates $347.80 million in revenue each year. The business services provider earns $41.30 million in net income (profit) each year or $1.07 on an earnings per share basis. Exponent employs 1,075 workers across the globe.

The official website for Exponent is http://www.exponent.com.

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]